Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2025-08-26 Audit Report / Informat…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Tekst jednolity statutu Selvita S.A._PL
Audit Report / Information Classification · 95% confidence The document is the 'Statut' (Articles of Association/Bylaws) of Selvita S.A., which outlines the company's general provisions, scope of activities, capital structure, and governance rules (roles of the General Meeting, Supervisory Board, and Management Board). This type of corporate governance document does not fit into financial reporting categories like 10-K or IR, nor is it a meeting announcement. It is a foundational regulatory document governing the company's internal structure, which falls under the 'Regulatory Filings' (RNS) category as a catch-all for corporate governance and legal foundational documents. FY 2025
2025-08-26 Polish
Rejestracja zmian Statutu Spółki / Registration of Articles of Association Amendments - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Selvita S.A. announcing the registration of a change to the company's articles of association (statute) by the National Court Register (KRS). It references a specific legal basis for current reports under Polish financial regulations. Since it is a formal announcement of a corporate governance change (statute amendment) and does not fit into specific categories like M&A, financial results, or director dealings, it is classified as a general regulatory filing.
2025-08-26 Polish
Otrzymanie istotnych zleceń przez spółkę zależną Selvita S.A. / Receipt of a significant orders by a company affiliated with Selvita S.A. - Content (EN)
Regulatory Filings Classification · 99% confidence The document announces the receipt of significant research orders by a subsidiary of Selvita S.A. from a major European pharmaceutical company. It details the nature of the work (ADME/DMPK, physicochemical profiling, analytical services, in-vivo PK studies), the value of the orders (EUR 2,800,000), and the duration. This type of announcement, detailing a material business contract or significant operational development that is not a standard periodic financial report (like 10-K or IR) or a management change, typically falls under general regulatory disclosure or a specific transaction/contract announcement. Since there is no specific code for 'Material Contract Award' and it is a formal announcement of a business event, it best fits the 'Regulatory Filings' (RNS) category as a miscellaneous regulatory disclosure, or potentially 'Capital/Financing Update' (CAP) if the contract was viewed as securing future revenue, but RNS is the most appropriate fallback for significant, non-standard operational news.
2025-07-22 English
Otrzymanie istotnych zleceń przez spółkę zależną Selvita S.A. / Receipt of a significant orders by a company affiliated with Selvita S.A. - Content (PL)
Regulatory Filings Classification · 95% confidence The document text is written in Polish and describes the receipt of three research service orders (Zlecenia) by a subsidiary (Selvita d.o.o.) from a major pharmaceutical company. It details the nature of the work (ADME/DMPK studies), the value of the orders (2,800,000 EUR), and confirms that this is a continuation of a long-term relationship. This type of announcement, detailing a significant new contract or business transaction that is material to the company's operations and strategy, typically falls under general regulatory disclosures or business updates. Since there is no specific category for 'Major Contract Award' and it is not a standard financial report (10-K, IR, ER), nor a management change (MANG) or director dealing (DIRS), it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard corporate announcements. Given the document length (1546 chars) and content (announcing a specific business event/contract), it is not a mere announcement of a report (RPA). It is the substance of the announcement itself. Therefore, RNS is the most appropriate classification.
2025-07-22 Polish
Powołanie Członków Zarządu Selvita S.A. na kolejną kadencję / Appointment of the Management Board Members of Selvita S.A. for the Next Term of Office - Content (EN)
Board/Management Information Classification · 100% confidence The document explicitly announces the appointment of Members of the Management Board of Selvita S.A. for the next term of office, detailing the names, roles (CEO, CFO, CCO, etc.), and extensive biographical information for each appointed member. This content directly aligns with the definition of 'Board/Management Information'.
2025-06-30 English
Powołanie Członków Zarządu Selvita S.A. na kolejną kadencję / Appointment of the Management Board Members of Selvita S.A. for the Next Term of Office - Content (PL)
Board/Management Information Classification · 100% confidence The document text is an official announcement from the Management Board ('Zarząd') of Selvita S.A. informing about the appointment of members of the Management Board ('Członków Zarządu') for a new term, effective June 30, 2025. It details the names, roles (CEO, CCO, etc.), extensive professional backgrounds, and compliance statements (not being in the Insolvent Debtors Register, no competing activities) for each appointed member. This content directly relates to changes in senior management personnel, which corresponds precisely to the definition of Board/Management Information.
2025-06-30 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.